durvalumab
astrazeneca
['biomarker', 'inspire']
#asco22 developmental therapeutics/io sci symposium: biomarkers of io vigex gene expression profile (hot/intermed cold/cold, incl pdl1) + ctdna is assoc with response to io across tumour types, validated in the ph ii inspire trial 
Thoracic Oncologist focused on immunotherapy for lung cancer & immune toxicity. Beaumont RCSI Cancer Centre Dublin; Adjunct Asst Prof Johns Hopkins University